|Bid||416.86 x 800|
|Ask||417.48 x 800|
|Day's range||414.64 - 423.14|
|52-week range||253.86 - 475.35|
|Beta (5Y monthly)||1.00|
|PE ratio (TTM)||74.86|
|Earnings date||20 Oct 2021 - 25 Oct 2021|
|Forward dividend & yield||0.68 (0.15%)|
|Ex-dividend date||20 Jul 2021|
|1y target est||423.00|
West Pharmaceutical (WST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Investors are optimistic about ResMed (RMD) owing to new product launches in the SDB market and strong sales of mask products.
Strength in Drug Development business and new strategies to expand into high-growth markets raise optimism for LabCorp (LH).